These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20307614)

  • 1. Src tyrosine kinase regulates angiotensin II-induced protein kinase Czeta activation and proliferation in vascular smooth muscle cells.
    Li L; Zhou Y; Wang C; Zhao YL; Zhang ZG; Fan D; Cui XB; Wu LL
    Peptides; 2010 Jun; 31(6):1159-64. PubMed ID: 20307614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation.
    Zhao Y; Liu J; Li L; Liu L; Wu L
    Regul Pept; 2005 May; 128(1):43-50. PubMed ID: 15721486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D; Shi X; Jiang BH; Fang J
    Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
    Walcher D; Babiak C; Poletek P; Rosenkranz S; Bach H; Betz S; Durst R; Grüb M; Hombach V; Strong J; Marx N
    Circ Res; 2006 Nov; 99(11):1181-7. PubMed ID: 17068290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells.
    Wang Y; Yan T; Wang Q; Wang W; Xu J; Wu X; Ji H
    Biochem Biophys Res Commun; 2008 Oct; 375(1):151-5. PubMed ID: 18687307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src tyrosine kinase regulates insulin-induced activation of protein kinase C (PKC) delta in skeletal muscle.
    Rosenzweig T; Aga-Mizrachi S; Bak A; Sampson SR
    Cell Signal; 2004 Nov; 16(11):1299-308. PubMed ID: 15337529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of pp60c-src in mitogen-activated protein kinase activation of vascular smooth muscle cells].
    Liu D; Lu JS; Yin XL
    Sheng Li Xue Bao; 2000 Dec; 52(6):483-6. PubMed ID: 11941412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential phosphorylation of calreticulin affects AT1 receptor mRNA stability in VSMC.
    Mueller CF; Wassmann K; Berger A; Holz S; Wassmann S; Nickenig G
    Biochem Biophys Res Commun; 2008 Jun; 370(4):669-74. PubMed ID: 18413143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK.
    Valkova C; Mertens C; Weisheit S; Imhof D; Liebmann C
    Mol Cancer Res; 2010 May; 8(5):783-97. PubMed ID: 20407013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of STAT-3 in the mediation of smooth muscle cell response to cyclic strain.
    Kakisis JD; Pradhan S; Cordova A; Liapis CD; Sumpio BE
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1396-406. PubMed ID: 15833272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained activation of Src-family tyrosine kinases by ischemia: a potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus.
    Guo J; Wu HW; Hu G; Han X; De W; Sun YJ
    Neuroscience; 2006 Dec; 143(3):827-36. PubMed ID: 17000055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
    Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
    Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.
    Touyz RM; Yao G; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):981-7. PubMed ID: 12663375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
    Chan SH; Wang LL; Tseng HL; Chan JY
    J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes.
    Clark MA; Gonzalez N
    Regul Pept; 2007 Oct; 143(1-3):47-55. PubMed ID: 17391778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells.
    Frank GD; Eguchi S; Motley ED; Sasaki T; Inagami T
    Biochem Biophys Res Commun; 2001 Aug; 286(4):692-6. PubMed ID: 11520052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCzeta-controlled ERK1/2 activity within the nucleus.
    Godeny MD; Sayeski PP
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1297-307. PubMed ID: 16723512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
    Goetze S; Xi XP; Graf K; Fleck E; Hsueh WA; Law RE
    FEBS Lett; 1999 Jun; 452(3):277-82. PubMed ID: 10386606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.